Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:6.3.2.3 (glutathione synthetase)
 678 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Glutathione (GSH) was shown to regulate the generation of IL-2-dependent activated killer cells. Generation of alpha CD3-activated killer cells CD3-AK was regulated by both IL-2 and IL-4. In the present study the role of GSH in the regulation of IL-4-dependent CD3-AK cells was examined. After initial activation of mouse splenocytes by alpha CD3, subculturing the CD3-AK cells in IL-4 resulted in the production of IL-4-dependent killer cells whose proliferative and cytolytic activities were abrogated by alpha IL-4 antibody 11B11. Adding graded doses of BSO, a GSH synthetase inhibitor, into CD3-AK cells culturing in IL-4 resulted in the reduction of their proliferative and cytotoxic responses. Adding exogenous GSH reversed the inhibitory effect of BSO and restored the proliferation and cytolytic activity of IL-4-dependent CD3-AK cells. The dose requirement for BSO to affect the IL-4-dependent CD3-AK cells was similar to that for the IL-2-dependent CD3-AK cells. These findings indicate that GSH also regulates the function of IL-4 in the activation and differentiation of CD3-AK cells. To further study the mechanism for the GSH regulation of the cytolytic activity of CD3-AK cells, we found that BSO did not reduce the production of BLT-esterase which contained mostly the cytolytic granules; in fact, BLT-esterase production was often increased by BSO. Furthermore, the exocytosis and effector function of cytolytic granules were also not affected by BSO. Thus it appears that reduction of cellular GSH may result in the accumulation of defective cytolytic granules which accounts for the reduction of killer cell cytolytic activity.
 ...
PMID:Regulation by glutathione of the activation and differentiation of IL-4-dependent activated killer cells. 833 Mar 19

The conversion of gamma-glutamylcysteinylethyl ester (gamma-GCE) to glutathione in a reduced form (GSH) was examined using isolated rat hepatocytes pretreated with diethylmaleate, a GSH-depletor. Incubation of hepatocytes with 0.1 and 5.0 mM gamma-GCE (gamma-GCE-hepatocytes) over a 30-min period resulted in time-dependent increases in intracellular GSH and nonprotein-SH (NP-SH) concentrations. Hepatocytes incubated with 5.0 mM but not 0.1 mM GSH over a period of 30 min showed a time-dependent increase in intracellular GSH concentration. In the gamma-GCE-hepatocytes pretreated with bis-(p-nitrophenyl)phosphate (BNPP), a non-specific esterase inhibitor, an enhancement of intracellular GSH concentration was markedly reduced. gamma-GCE concentration in the gamma-GCE-hepatocytes with BNPP pretreatment was significantly higher than that in the cells without BNPP pretreatment, although there was no difference in the total amount of intracellular NP-SH, i.e., gamma-GCE, GSH, gamma-glutamylcysteine, cysteine ethyl ester, and cysteine between both gamma-GCE-hepatocytes. The present results indicate that gamma-GCE is transported into liver cells more easily than GSH itself, resulting in its conversion to GSH via esterase and glutathione synthetase within the cells.
 ...
PMID:Conversion of gamma-glutamylcysteinylethyl ester to glutathione in rat hepatocytes. 878 49

The role of endogenous reduced glutathione (GSH) in tert-butyl hydroperoxide (TBHP)-induced cell injury was examined in isolated rat hepatocytes. When liver cell injury was estimated from release of transaminases from hepatocytes into the incubation medium, cell injury in hepatocytes (2 x 10(6) cells/ml) incubated in Hanks' balanced salt solution (pH 7.2) containing 1.0 mM TBHP at 37 degrees C was potentiated with enhanced lipid peroxidation by prior depletion of intracellular GSH which was induced by diethylmaleate, a GSH depletor. GSH-depleted hepatocytes were incubated with gamma-glutamylcysteinylethyl ester (gamma-ECOEt), which is known to be converted to GSH via glutathione synthetase after its hydrolysis by esterase, at concentrations of 1.0 to 10 mM in order to replenish intracellular GSH. Although TBHP-induced cell injury and lipid peroxidation were enhanced in GSH-depleted hepatocytes, these enhancements were prevented with the consumption of intracellular GSH in GSH-depleted hepatocytes pretreated with 5.0 mM gamma-ECOEt. These preventive effects were observed at any time point during the TBHP treatment over a 60 min period and depended on the concentration of gamma-ECOEt used. But, no preventive effect was found in GSH-depleted hepatocytes pretreated with 5.0 mM GSH. No prevention of the potentiation of TBHP-induced cell injury found in GSH-depleted hepatocytes occurred in GSH-depleted hepatocytes pretreated with both 5.0 mM gamma-ECOEt and 250 microM bis-(p-nitrophenyl)phosphate, a nonspecific esterase inhibitor. gamma-ECOEt treatment caused an increase in intracellular GSH content in GSH-depleted hepatocytes, while treatments of both gamma-ECOEt and the esterase inhibitor caused no increase in intracellular GSH content in the cells. These results indicate that endogenous GSH modulates TBHP-induced cell injury and lipid peroxidation in isolated rat hepatocytes. The present results suggest that endogenous GSH should play a critical role in TBHP-induced cell injury in isolated rat hepatocytes and that in rat hepatocytes treated with TBHP, enhanced lipid peroxidation with the consumption of intracellular GSH could be associated with the initiation of cell injury.
 ...
PMID:Modulating role of endogenous reduced glutathione in tert-butyl hydroperoxide-induced cell injury in isolated rat hepatocytes. 921 82